Crescent Biopharma (CBIO) announced the appointment of Jan Pinkas, Ph.D., as chief scientific officer. Prior to joining Crescent, Dr. Pinkas was CSO at Pyxis Oncology (PYXS), where he established the preclinical research and development function to support ADC and antibody programs through Investigational New Drug-enabling studies and led the translational medicine group.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CBIO: